JP2017529346A5 - - Google Patents

Download PDF

Info

Publication number
JP2017529346A5
JP2017529346A5 JP2017514615A JP2017514615A JP2017529346A5 JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5 JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017514615 A JP2017514615 A JP 2017514615A JP 2017529346 A5 JP2017529346 A5 JP 2017529346A5
Authority
JP
Japan
Prior art keywords
pyrimidin
pharmaceutically acceptable
acceptable salt
pyrido
phenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017514615A
Other languages
English (en)
Japanese (ja)
Other versions
JP6552608B2 (ja
JP2017529346A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/050432 external-priority patent/WO2016044429A1/en
Publication of JP2017529346A publication Critical patent/JP2017529346A/ja
Publication of JP2017529346A5 publication Critical patent/JP2017529346A5/ja
Application granted granted Critical
Publication of JP6552608B2 publication Critical patent/JP6552608B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017514615A 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤 Expired - Fee Related JP6552608B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462051691P 2014-09-17 2014-09-17
US62/051,691 2014-09-17
PCT/US2015/050432 WO2016044429A1 (en) 2014-09-17 2015-09-16 Histone demethylase inhibitors

Publications (3)

Publication Number Publication Date
JP2017529346A JP2017529346A (ja) 2017-10-05
JP2017529346A5 true JP2017529346A5 (enExample) 2018-10-25
JP6552608B2 JP6552608B2 (ja) 2019-07-31

Family

ID=55525128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017514615A Expired - Fee Related JP6552608B2 (ja) 2014-09-17 2015-09-16 ヒストンデメチラーゼ阻害剤

Country Status (17)

Country Link
US (7) US9643965B2 (enExample)
EP (2) EP3193601B1 (enExample)
JP (1) JP6552608B2 (enExample)
KR (1) KR20170048591A (enExample)
CN (1) CN107205391A (enExample)
AU (1) AU2015317806A1 (enExample)
BR (1) BR112017005511A2 (enExample)
CA (1) CA2961610A1 (enExample)
CL (1) CL2017000659A1 (enExample)
CO (1) CO2017003538A2 (enExample)
EA (1) EA201790603A1 (enExample)
EC (1) ECSP17023551A (enExample)
ES (1) ES2910226T3 (enExample)
IL (1) IL251179A0 (enExample)
MX (1) MX2017003466A (enExample)
SG (1) SG11201702147TA (enExample)
WO (1) WO2016044429A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2970211T (lt) 2013-03-15 2017-10-25 Quanticel Pharmaceuticals Inc Histono demetilazės inhibitoriai
AU2015317806A1 (en) 2014-09-17 2017-04-13 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
ES2921009T3 (es) * 2016-03-15 2022-08-16 Celgene Quanticel Res Inc Inhibidores de desmetilasas de histonas
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
CN109996800B (zh) 2016-11-28 2021-11-19 帝人制药株式会社 吡啶并[3,4-d]嘧啶衍生物或其溶剂合物的晶体
CN110662536B (zh) * 2017-03-29 2023-06-23 普渡研究基金会 激酶网络抑制剂及其用途
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116253712B (zh) * 2023-03-27 2025-05-02 昆山市第一人民医院 5,6,7-三甲氧基-2,3-二氢喹啉类化合物、药物组合物及用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003033472A1 (en) * 2001-10-17 2003-04-24 Kirin Beer Kabushiki Kaisha Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors
ATE468336T1 (de) 2002-03-15 2010-06-15 Vertex Pharma Azolylaminoazine als proteinkinasehemmer
MXPA05012839A (es) * 2003-05-27 2006-05-17 Pfizer Prod Inc Quinazolinas y pirido[3,4-d] pirimidinas como inhibidores de receptores tirosina quinasa.
US7544677B2 (en) * 2004-08-23 2009-06-09 Merck & Co., Inc. Inhibitors of Akt activity
FR2876103B1 (fr) 2004-10-01 2008-02-22 Aventis Pharma Sa Nouveaux derives bis-azaindoles, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
EP2061772A4 (en) 2006-09-11 2011-06-29 Curis Inc MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES
TW200922590A (en) 2007-09-10 2009-06-01 Curis Inc VEGFR inhibitors containing a zinc binding moiety
JP5552608B2 (ja) 2012-04-27 2014-07-16 株式会社ソフイア 遊技機
US20150203453A1 (en) 2012-10-02 2015-07-23 Epitherapeutics Aps Inhibitors of histone demethylases
WO2014100463A1 (en) 2012-12-19 2014-06-26 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
ES2718495T3 (es) 2012-12-21 2019-07-02 Celgene Quanticel Res Inc Inhibidores de la histona desmetilasa
EP2968282B1 (en) 2013-03-12 2018-05-09 Celgene Quanticel Research, Inc. Histone dementhylase inhibitors
LT2970211T (lt) 2013-03-15 2017-10-25 Quanticel Pharmaceuticals Inc Histono demetilazės inhibitoriai
MX2015011899A (es) 2013-03-15 2016-05-05 Genentech Inc Metodos para el tratamiento de cáncer y prevención de resistencia a los fármacos para el cáncer.
SG11201610813TA (en) 2014-06-25 2017-01-27 Quanticel Pharmaceuticals Inc Histone demethylase inhibitors
AU2015317806A1 (en) 2014-09-17 2017-04-13 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US10030017B2 (en) 2014-09-17 2018-07-24 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
ES2921009T3 (es) 2016-03-15 2022-08-16 Celgene Quanticel Res Inc Inhibidores de desmetilasas de histonas

Similar Documents

Publication Publication Date Title
JP2017529346A5 (enExample)
JP2024153683A (ja) NaV1.8を阻害するピリジンカルボキサミド化合物
JP2023027269A5 (enExample)
JP2017530962A5 (enExample)
HRP20151001T4 (hr) Sredstva kao induktori apoptoze za liječenje raka te imunih i autoimunih bolesti
RU2004117887A (ru) Ариланилиновые агонисты бета2 адренергических рецепторов
HRP20141094T1 (hr) 1,2,5-oksadiazoli kao inhibitori indolamin 2,3-dioksigenaze
JP2010517946A5 (enExample)
HRP20200341T1 (hr) Bromodomenski (bet) inhibitori
JP2007523867A5 (enExample)
JP2008110984A5 (enExample)
CA2658359A1 (en) Heterocyclic compounds and methods of use
JP2013542937A5 (enExample)
JP2004525951A5 (enExample)
JP2013505969A5 (enExample)
JP2005509024A5 (enExample)
JP2018507899A5 (enExample)
JP2013532727A5 (enExample)
JP2017527561A5 (enExample)
JP2016501250A5 (enExample)
RU2008136553A (ru) Производные бензотиазола в качестве агонистов бета2 адренорецептора
JP2010501587A5 (enExample)
JP2012255002A5 (enExample)
JP2013534245A5 (enExample)
JP2007501831A5 (enExample)